TCFmlg is made and published by Poni Lai. AppBrain is an independent app data site and isn't affiliated with Poni Lai. The app name, icon, screenshots and description belong to Poni Lai and are shown as published on the App Store.
AppBrain's verdict
- Last updated
- August 25, 2021
- Size
- 15.4 MB
User feedback
Ratings and reviews on the App StoreComments on TCFmlg for iOS
We don't have enough comments to show example comments. Please check back later.
Store listing
By Poni Lai, from the App StoreDescription by Poni Lai Written by the developer, not by AppBrain. Click to read.
Safety and technology
Found in the app by AppBrain- Price
- Free
- App size
- 15.4 MB
- Content rating
- Everyone
Technologies used by TCFmlg
Releases
Updates seen on the App Store- Version
- 2.3
- Launched
- February 2020
No changelog data
Alternatives
Similar apps and more from Poni LaiAlternatives to TCFmlg
More from Poni Lai
Rankings
App Store top chartsApp Store Rankings for TCFmlg
About the app and developer
About TCFmlg
TCFmlg is a medical app developed by Poni Lai.
What is the rating of TCFmlg?
TCFmlg has no ratings yet.
Is TCFmlg free?
TCFmlg is free. The app size is 15.44 MB. The latest version available is 2.3. The last update was on August 25, 2021.
What are the requirements for TCFmlg?
The app has a content rating of Everyone. The app has been available on the App Store since February 2020.
Developer information for Poni Lai
Address:
Frequently asked questions about TCFmlg
Is TCFmlg free?
Yes. TCFmlg is free on the App Store.
Is TCFmlg still available?
Yes. TCFmlg is on the App Store, and the last update we saw was on August 25, 2021.
How large is TCFmlg?
TCFmlg is 15.44 MB.
Is TCFmlg suitable for children?
App Store rates the content of TCFmlg as suitable for everyone.
Who made TCFmlg?
TCFmlg was developed by Poni Lai. It is listed in the medical category on the App Store.
What are the best alternatives to TCFmlg?
People looking at TCFmlg also look at these medical apps: Tesla Wave LLC, smop, ClearCorrect Sync, Solutionist - AramHuvis, iFORA O2.